Roles of endothelial cell specific molecule‑1 in tumor angiogenesis (Review)
- Authors:
- Jie Zhou
- Ping Zhou
- Jinfang Wang
- Jie Song
-
Affiliations: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China, College of Chinese Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China, College of Nursing, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China - Published online on: February 1, 2024 https://doi.org/10.3892/ol.2024.14270
- Article Number: 137
-
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Qi S, Deng S, Lian Z and Yu K: Novel drugs with high efficacy against tumor angiogenesis. Int J Mol Sci. 23:69342022. View Article : Google Scholar : PubMed/NCBI | |
|
Pan KF, Yang YC, Lee WJ, Hua KT and Chien MH: Proteoglycan endocan: A multifaceted therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer. 1877:1886722022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Jiang L, Yu XH, Hu M, Zhang YK, Liu X, He P and Ouyang X: Endocan: A key player of cardiovascular disease. Front Cardiovasc Med. 8:7986992022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W and Wang Y: Expression and distribution of endocan in human tissues. Biotech Histochem. 87:172–178. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lu J, Liu Q, Zhu L, Liu Y, Zhu X, Peng S, Chen M and Li P: Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell Death Dis. 13:10432022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Yang Y, He B, Ma F, Sun F, Guo M, Zhang M and Dong Z: ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway. Ann Transl Med. 9:5332021. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Yang D, Zhang C, Wei S, Zhao R, Dai S and Shan B: ESM1 is a promising therapeutic target and prognostic indicator for esophageal Carcinogenesis/Esophageal squamous cell carcinoma. Biomed Res Int. 2022:53281922022.PubMed/NCBI | |
|
Abid MR, Yi X, Yano K, Shih SC and Aird WC: Vascular endocan is preferentially expressed in tumor endothelium. Microvasc Res. 72:136–145. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen LY, Liu X, Wang SL and Qin CY: Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res. 38:498–510. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R and Tonnel AB: ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 271:20458–20464. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Kali A and Shetty KS: Endocan: A novel circulating proteoglycan. Indian J Pharmacol. 46:579–583. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P and Delehedde M: Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 1765:25–37. 2006.PubMed/NCBI | |
|
Delehedde M, Devenyns L, Maurage CA and Vivès RR: Endocan in cancers: A lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013:7050272013. View Article : Google Scholar : PubMed/NCBI | |
|
Béchard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, et al: Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 276:48341–48349. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
De Freitas Caires N, Gaudet A, Portier L, Tsicopoulos A, Mathieu D and Lassalle P: Endocan, sepsis, pneumonia, and acute respiratory distress syndrome. Crit Care. 22:2802018. View Article : Google Scholar : PubMed/NCBI | |
|
Leite AR, Borges-Canha M, Cardoso R, Neves JS, Castro-Ferreira R and Leite-Moreira A: Novel biomarkers for evaluation of endothelial dysfunction. Angiology. 71:397–410. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yu PH, Chou SF, Chen CL, Hung H, Lai CY, Yang PM, Jeng YM, Liaw SF, Kuo HH, Hsu HC, et al: Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma. PLoS One. 8:e822542013. View Article : Google Scholar : PubMed/NCBI | |
|
Laloglu E, Kumtepe Y, Aksoy H and Topdagi Yilmaz EP: Serum endocan levels in endometrial and ovarian cancers. J Clin Lab Anal. 31:e220792017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu H, Chen X and Huang Z: Identification of ESM1 overexpressed in head and neck squamous cell carcinoma. Cancer Cell Int. 19:1182019. View Article : Google Scholar : PubMed/NCBI | |
|
Baghy K, Tátrai P, Regős E and Kovalszky I: Proteoglycans in liver cancer. World J Gastroenterol. 22:379–393. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cai L, Leng ZG, Guo YH, Lin SJ, Wu ZR, Su ZP, Lu JL, Wei LF, Zhuge QC, Jin K and Wu ZB: Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine. 52:641–651. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chang Y, Niu W, Lian PL, Wang XQ, Meng ZX, Liu Y and Zhao R: Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer. World J Gastroenterol. 22:5422–5429. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Shen YW, Zhang LJ, Chen JJ, Bian HT, Gu WJ, Zhang H, Chen HZ, Zhang WD and Luan X: Targeting endothelial cell-specific molecule 1 protein in cancer: A promising therapeutic approach. Front Oncol. 11:6871202021. View Article : Google Scholar : PubMed/NCBI | |
|
Zolali E, Rezabakhsh A, Nabat E, Jaberi H, Rahbarghazi R and Garjani A: Metformin effect on Endocan biogenesis in human endothelial cells under diabetic condition. Arch Med Res. 50:304–314. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng M, Xie Z, Zhang J, Li S, Wu Y and Yan X: Arctigenin attenuates vascular inflammation induced by high salt through TMEM16A/ESM1/VCAM-1 pathway. Biomedicines. 10:27602022. View Article : Google Scholar : PubMed/NCBI | |
|
Hortal J, Giannella M, Pérez MJ, Barrio JM, Desco M, Bouza E and Muñoz P: Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med. 35:1518–1525. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J, Ioffe E, Daly TJ, Fandl JP, Papadopoulos N, et al: Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA. 103:15491–15496. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Baeriswyl V and Christofori G: The angiogenic switch in carcinogenesis. Semin Cancer Biol. 19:329–337. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Apte RS, Chen DS and Ferrara N: VEGF in signaling and disease: Beyond discovery and development. Cell. 176:1248–1264. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ellis LM and Hicklin DJ: VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 161:851–858. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Duran CL, Borriello L, Karagiannis GS, Entenberg D, Oktay MH and Condeelis JS: Targeting Tie2 in the tumor microenvironment: From Angiogenesis to Dissemination. Cancers (Basel). 13:57302021. View Article : Google Scholar : PubMed/NCBI | |
|
Bremnes RM, Camps C and Sirera R: Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer. 51:143–158. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Huang H: Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances. Sensors (Basel). 18:32492018. View Article : Google Scholar : PubMed/NCBI | |
|
Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rust R, Gantner C and Schwab ME: Pro- and antiangiogenic therapies: Current status and clinical implications. FASEB J. 33:34–48. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Viallard C and Larrivée B: Tumor angiogenesis and vascular normalization: Alternative therapeutic targets. Angiogenesis. 20:409–426. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Phng LK, Stanchi F and Gerhardt H: Filopodia are dispensable for endothelial tip cell guidance. Development. 140:4031–4040. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Barău A, Ruiz-Sauri A, Valencia G, Gómez-Mateo Mdel C, Sabater L, Ferrandez A and Llombart-Bosch A: High microvessel density in pancreatic ductal adenocarcinoma is associated with high grade. Virchows Arch. 462:541–546. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Di Maggio F, Arumugam P, Delvecchio FR, Batista S, Lechertier T, Hodivala-Dilke K and Kocher HM: Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma. Pancreatology. 16:995–1004. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ramjiawan RR, Griffioen AW and Duda DG: Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis. 20:185–204. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK and McDonald DM: Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol. 160:985–1000. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Dejana E, Tournier-Lasserve E and Weinstein BM: The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev Cell. 16:209–221. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Baluk P, Morikawa S, Haskell A, Mancuso M and McDonald DM: Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol. 163:1801–1815. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Rocha SF, Schiller M, Jing D, Li H, Butz S, Vestweber D, Biljes D, Drexler HC, Nieminen-Kelhä M, Vajkoczy P, et al: Esm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability. Circ Res. 115:581–590. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Su T, Zhong Y, Demetriades AM, Shen J, Sui A, Yao Y, Gao Y, Zhu Y, Shen X and Xie B: Endocan blockade suppresses experimental ocular neovascularization in mice. Invest Ophthalmol Vis Sci. 59:930–939. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li YK, Zeng T, Guan Y, Liu J, Liao NC, Wang MJ, Chen KX, Luo XY, Chen CY, Quan FF, et al: Validation of ESM1 related to ovarian cancer and the biological function and prognostic significance. Int J Biol Sci. 19:258–280. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
He Y, Lin L, Ou Y, Hu X, Xu C and Wang C: Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer. Open Med (Wars). 17:1376–1389. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Su X, Xue S, Yao L, Yu D, Tang X and Huang Y: Targeting ESM1/VEGFα signaling axis: A promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma. J Cancer. 14:1725–1735. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, Rogler A, Stöhr R, Hartmann A, Provenzano M, et al: Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 73:1097–1106. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shahcheraghi SH, Tchokonte-Nana V, Lotfi M, Lotfi M, Ghorbani A and Sadeghnia HR: Wnt/beta-catenin and PI3K/Akt/mTOR signaling pathways in Glioblastoma: Two main targets for drug design: A Review. Curr Pharm Des. 26:1729–1741. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Dong Z, Li S and Chen T: ESM1 promotes angiogenesis in colorectal cancer by activating PI3K/Akt/mTOR pathway, thus accelerating tumor progression. Aging (Albany NY). 15:2920–2936. 2023.PubMed/NCBI | |
|
Namjoo M, Ghafouri H, Assareh E, Aref AR, Mostafavi E, Hamrahi Mohsen A, Balalaie S, Broussy S and Asghari SM: A VEGFB-based peptidomimetic inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK signaling and elicits apoptotic, antiangiogenic, and antitumor activities. Pharmaceuticals (Basel). 16:9062023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang YC, Pan KF, Lee WJ, Chang JH, Tan P, Gu CC, Chang WM, Yang SF, Hsiao M, Hua KT and Chien MH: Circulating proteoglycan endocan mediates EGFR-Driven progression of non-small cell lung cancer. Cancer Res. 80:3292–3304. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Rao L, Giannico D, Leone P, Solimando AG, Maiorano E, Caporusso C, Duda L, Tamma R, Mallamaci R, Susca N, et al: HB-EGF-EGFR signaling in bone marrow endothelial cells mediates angiogenesis associated with multiple myeloma. Cancers (Basel). 12:1732020. View Article : Google Scholar : PubMed/NCBI | |
|
Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y and Hu LL: ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 19:1997–2007. 2020.PubMed/NCBI | |
|
Lee W, Ku SK, Kim SW and Bae JS: Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol. 229:620–630. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Guma M, Rius J, Duong-Polk KX, Haddad GG, Lindsey JD and Karin M: Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. Proc Natl Acad Sci USA. 106:8760–8765. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Volpi G, Facchinetti F, Moretto N, Civelli M and Patacchini R: Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br J Pharmacol. 163:649–661. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Ji Q and Li Q: Resistance to anti-EGFR therapies in metastatic colorectal cancer: Underlying mechanisms and reversal strategies. J Exp Clin Cancer Res. 40:3282021. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang N, Hu Y, Wang M, Zhao Z and Li M: The notch signaling pathway contributes to angiogenesis and tumor immunity in breast cancer. Breast Cancer (Dove Med Press). 14:291–309. 2022.PubMed/NCBI | |
|
Kang N, Liang X, Fan B, Zhao C, Shen B, Ji X and Liu Y: Endothelial-Specific Molecule 1 inhibition lessens productive angiogenesis and tumor metastasis to overcome bevacizumab resistance. Cancers (Basel). 14:56812022. View Article : Google Scholar : PubMed/NCBI | |
|
Huang YG, Wang Y, Zhu RJ, Tang K, Tang XB and Su XM: EMS1/DLL4-Notch signaling axis augments cell cycle-mediated tumorigenesis and progress in human adrenocortical carcinoma. Front Oncol. 11:7715792021. View Article : Google Scholar : PubMed/NCBI | |
|
Yan M and Plowman GD: Delta-like 4/Notch signaling and its therapeutic implications. Clin Cancer Res. 13:7243–7246. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pitulescu ME, Schmidt I, Giaimo BD, Antoine T, Berkenfeld F, Ferrante F, Park H, Ehling M, Biljes D, Rocha SF, et al: Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. Nat Cell Biol. 19:915–927. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gilmore TD: NF-κB and human cancer: What have we learned over the Past 35 Years? Biomedicines. 9:8892021. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar SK and Mani KP: Endocan alters nitric oxide production in endothelial cells by targeting AKT/eNOS and NFkB/iNOS signaling. Nitric Oxide. 117:26–33. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu M, Qi B, Xiaoxiang W, Xu J and Liu X: Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Biomed Pharmacother. 90:677–685. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang D, Li H, Luo X, Liu D, Wei Q and Ye X: Integrated 16S rDNA, metabolomics, and TNF-α/NF-κB signaling pathway analyses to explain the modulatory effect of Poria cocos aqueous extract on anxiety-like behavior. Phytomedicine. 104:1543002022. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong H, Ye J, Xie K, Hu W, Xu N and Yang H: Exosomal IL-8 derived from Lung Cancer and Colon Cancer cells induced adipocyte atrophy via NF-κB signaling pathway. Lipids Health Dis. 21:1472022. View Article : Google Scholar : PubMed/NCBI | |
|
Szade A, Grochot-Przeczek A, Florczyk U, Jozkowicz A and Dulak J: Cellular and molecular mechanisms of inflammation-induced angiogenesis. IUBMB Life. 67:145–159. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao Y and Yu D: Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 221:1077532021. View Article : Google Scholar : PubMed/NCBI | |
|
Shao C, Yang F, Miao S, Liu W, Wang C, Shu Y and Shen H: Role of hypoxia-induced exosomes in tumor biology. Mol Cancer. 17:1202018. View Article : Google Scholar : PubMed/NCBI | |
|
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 16:4604–4613. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Lv X, Li J, Zhang C, Hu T, Li S, He S, Yan H, Tan Y, Lei M, Wen M and Zuo J: The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism. Genes Dis. 4:19–24. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun H, Zhang H, Li K, Wu H, Zhan X, Fang F, Qin Y and Wei Y: ESM-1 promotes adhesion between monocytes and endothelial cells under intermittent hypoxia. J Cell Physiol. 234:1512–1521. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fukumoto M, Kondo K, Uni K, Ishiguro T, Hayashi M, Ueda S, Mori I, Niimi K, Tashiro F, Miyazaki S, et al: Tip-cell behavior is regulated by transcription factor FoxO1 under hypoxic conditions in developing mouse retinas. Angiogenesis. 21:203–214. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gu X, Zhang J, Shi Y, Shen H, Li Y, Chen Y and Liang L: ESM1/HIF-1α pathway modulates chronic intermittent hypoxia-induced non-small-cell lung cancer proliferation, stemness and epithelial-mesenchymal transition. Oncol Rep. 45:1226–1234. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wigner P, Grębowski R, Bijak M, Saluk-Bijak J and Szemraj J: The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development. Int J Mol Sci. 22:44832021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu L, Saxena S and Singh RK: Neutrophils in the tumor microenvironment. Adv Exp Med Biol. 1224:1–20. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tang L, Zhao Y, Wang D, Deng W, Li C, Li Q, Huang S and Shu C: Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Mediators Inflamm. 2014:6251802014. View Article : Google Scholar : PubMed/NCBI | |
|
Reinhart K, Meisner M and Brunkhorst FM: Markers for sepsis diagnosis: What is useful? Crit Care Clin. 22:503–519. ix–x. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kim KS, Lee YA, Ji HI, Song R, Kim JY, Lee SH, Hong SJ, Yoo MC and Yang HI: Increased expression of endocan in arthritic synovial tissues: Effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes. Mol Med Rep. 11:2695–2702. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Murthi P, Sarkis R, Lim R, Nguyen-Ngo C, Pratt A, Liong S and Lappas M: Endocan expression is increased in the placenta from obese women with gestational diabetes mellitus. Placenta. 48:38–48. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC and Lassalle P: Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 56:180–187. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Basim P and Argun D: A comparison of the circulating endocan levels between the inflammatory and malignant diseases of the same organ: The breast. J Invest Surg. 34:1207–1213. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Scherpereel A, Gentina T, Grigoriu B, Sénéchal S, Janin A, Tsicopoulos A, Plénat F, Béchard D, Tonnel AB and Lassalle P: Overexpression of endocan induces tumor formation. Cancer Res. 63:6084–6089. 2003.PubMed/NCBI | |
|
Steiner N, Hajek R, Sevcikova S, Borjan B, Untergasser G, Göbel G and Gunsilius E: The plasma levels of the angiogenic cytokine endocan are elevated in patients with multiple myeloma. Anticancer Res. 38:5087–5092. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T and Tsutsumi M: Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer. 5:221–230. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin LY, Yeh YC, Chu CH, Won JGS, Shyr YM, Chao Y, Li CP, Wang SE and Chen MH: Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors. Medicine (Baltimore). 96:e82622017. View Article : Google Scholar : PubMed/NCBI | |
|
Maurage CA, Adam E, Minéo JF, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S and Delehedde M: Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol. 68:633–641. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY and Xu L: Prognostic value of endocan expression in cancers: Evidence from meta-analysis. Onco Targets Ther. 9:6297–6304. 2016. View Article : Google Scholar : PubMed/NCBI |
